Navigation Links
NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)
Date:11/16/2009

b>About Qutenza

Qutenza(TM) (capsaicin) 8% patch is a dermal delivery system that contains a prescription strength of capsaicin approved in the United States for the management of PHN. Qutenza is designed to reduce the pain associated with PHN after a single one hour administration. The capsaicin in Qutenza is a synthetic equivalent of a naturally occurring compound found in chili peppers. Qutenza has also been approved in the European Union.

Please see the complete prescribing information and visit the Qutenza Web site at www.Qutenza.com.

Conference Call Details

The Company will hold a conference call tomorrow morning, November 17, 2009 at 8:30 a.m. ET (5:30 a.m. PT) to discuss the FDA approval of Qutenza for the treatment of PHN.

To participate, please dial 1-877-407-0789 (USA) or 1-201-689-8562 (International). To access the live web cast please visit the Investor Relations section on the corporate web site at www.neurogesx.com.

A replay of the conference call will be available beginning November 17, 2009 at 11:30 a.m. ET (8:30 a.m. PT) and ending on December 17, 2009 by dialing 1-877-660-6853 (USA) or 1-201-612-7415 (International), Account Number: 3055, Conference ID Number: 338031. A replay of the webcast will also be available on the corporate website for one month, through December 17, 2009.

About NeurogesX, Inc.

NeurogesX is a San Francisco Bay Area-based biopharmaceutical company focused on developing and commercializing novel pain management therapies. NeurogesX was founded on the concept that use of prescription strength capsaicin could help manage the pain associated with neuropathic pain conditions. Since its inception, NeurogesX has leveraged its passion to help people with pain to efficiently develop this concept and
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NeurogesX Expands Commercial Operations Leadership Team
2. NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
3. NeurogesX to Present at JMP Securities Healthcare Focus Conference
4. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
5. NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
6. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
7. NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation
8. NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
9. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
10. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
11. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com announces ... in its catalogue: Global Animal Health ... About Animal Health Animal health refers ... or treat animals to enhance their quality of ... of animal food. The Global Animal Health market ...
(Date:8/27/2014)... 2014 Sihuan Pharmaceutical Holdings Group Ltd. ... leading pharmaceutical company with the largest cardio-cerebral vascular ... prescription drug market, today announced the unaudited ... (collectively the "Group") for the six months ended ... HighlightsFor the Six months ended 30 JuneKey Income ...
(Date:8/27/2014)... , Aug. 27, 2014 ... research report is available in its ... for Application and Approval of Imported ... Practices (2014 Edition) ... Now, Chinese regulations on medical ...
Breaking Medicine Technology:Global Animal Health Market 2014-2018 2Global Animal Health Market 2014-2018 3Global Animal Health Market 2014-2018 4Global Animal Health Market 2014-2018 5Global Animal Health Market 2014-2018 6Global Animal Health Market 2014-2018 7Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10
... 10 Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), ... the treatment of cancer and,hepatitis C virus (HCV) ... protocol with the Drug Controller General of India ... efficacy trial of bavituximab in combination,with the chemotherapy ...
... Results in 2.7 log10 (>99%) Mean HCV RNA Decrease with No ... Serious Adverse Events - ... 8:30AM (ET) Today -, PRINCETON, N.J., Sept. 10 Pharmasset, Inc.,(Nasdaq: ... of monotherapy in 40 patients chronically,infected with hepatitis C virus (HCV) who have ...
Cached Medicine Technology:Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 4R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 2R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 3R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 4R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 5R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 6
(Date:8/28/2014)... 2014 The Foundation for Women’s ... in September by alerting women to the link between ... the symptoms of endometrial cancer. , Endometrial cancer ... most common cancer. More than 52,600 will learn of ... for women with weight management challenges to know the ...
(Date:8/28/2014)... PA (PRWEB) August 28, 2014 ... one of its clients, an inventor from California, has ... abdominal area. This invention is patented. , The “Abdominal ... to minimize the risk of injuries from physical activity ... due to surgery or muscular atrophy. Ideal for ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Altec ... and workflow solutions, announced today that they have ... the SoCal Chapter of the International Association of ... Services. IAMCP was founded in 1994, providing Microsoft ... and the IT community at large while facilitating ...
(Date:8/28/2014)... Dr. Stewart Shofner of ... the summer that recently headed off to college. According ... over 22 million students will attend college or university ... time attending classes, studying for exams, participate in sports ... eye problems. , Dr. Stewart Shofner shares five ...
(Date:8/28/2014)... Lauderdale, Fla. (PRWEB) August 28, 2014 A ... about the possibility of suicide contagion as a result of ... headlines, there is an increased risk of ‘copycat suicides’ among ... that the focus should not be on what happened—the suicide ... that lead to suicide. , “Suicide is a tragedy ...
Breaking Medicine News(10 mins):Health News:Foundation for Women's Cancer Alerts Women to Link Between Obesity and Endometrial Cancer 2Health News:InventHelp® Client Patents “Abdominal Swimming Support” – Invention Could Serve as an Alternative Flotation Device 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 3Health News:Renowned Eye Surgeon Dr. Shofner Shares Five Important Vision Tips For College Students 2Health News:Renowned Eye Surgeon Dr. Shofner Shares Five Important Vision Tips For College Students 3Health News:Sylvia Brafman Mental Health Center Warns of Suicide Contagion Following Robin Williams’ Death 2
... discovered by researchers at the University of North Carolina at ... forms of pancreatic cancer//, according to a study by an ... discovered six years ago by Dr. Carol Otey and her ... Brigham and Women’s Hospital in Boston. Otey has shown that ...
... An index comprising of the basic symptoms associated with ... its early stages, according to a new study.// This ... screening tool. ,The details of this study ... CANCER (http://www.interscience.wiley.com/cancer-newsroom), a peer-reviewed journal of the American Cancer ...
... H5N1 Outbreak as the Flu killed thousands of quails at a ... quails died over the weekend at a farm in Kimje, 262 ... have begun to cull the quails in the farm of the ... the third case since November 23 starting with an first outbreak ...
... Queensland (Australia) government has decided //to toughen its laws on ... cars carrying children. This comes in the wake of ... age, dies every 18 days, when exposed to cigarette smoke. ... of Queenslanders Report, 2006, made these comments. ,A ...
... Washington University School of Medicine have found out that successful ... dependence in many smokers. This study published in the December ... to look at smoking relapse among people who were "forced" ... has found that close to half of 154 smokers who ...
... face any kind of unforeseen pandemic, the province of Ontario ... disease control.// The officials, plan to form the centre on ... situated in Atlanta, U.S. ,Canadian media, quoting government ... intends to initiate proceedings to frame legislation, on the 12th ...
Cached Medicine News:Health News:Gene Discovered by Researchers Tied to Pancreatic Cancer 2Health News:A Basic Symptom Index For Early Detection Of Ovarian Cancer 2Health News:Lung Cancer Surgeries Doesn’t Help Breaking Nicotine Dependence in Smoker 2Health News:Lung Cancer Surgeries Doesn’t Help Breaking Nicotine Dependence in Smoker 3
... benchtop coagulation analyzers feature Stago's ... detection. This method eliminates interference ... optically dense samples or reagents. ... preprogrammed assays with curve storage, ...
The CA-50 is a compact semi-automated coagulation analyzerproviding 4-parameter random access....
HemoSite meter can be used to measure the effects of transfusion or the treatment of deficiency states. It is fast, easy, convenient and discrete....
... II is a fully automated analyzer that ... hands-on time by the operator. The Variant ... specimen tubes. It reads the bar code, ... injects the specimen into the chromatographic station ...
Medicine Products: